Christopher Davies, JD, joined the Dana-Farber Innovations team in 2020. Christopher supports Dana-Farber researchers in all efforts related to intellectual property strategy and commercialization, as well as negotiation and management of agreements that facilitate non-clinical research. He brings nearly a decade of experience in grant management and legal support. Prior to joining Dana-Farber, he held various positions at Harvard Medical School and Nixon Peabody LLP.
Davies received his Juris Doctor in 2015 from New England School of Law, with a specific concentration in Intellectual Property Law, after completing his undergraduate degree in Biology at the University of Massachusetts-Amherst. He is a registered patent agent with the United States Patent and Trademark Office (USPTO) and is registered to practice law in the Commonwealth of Massachusetts.